Keyphrases
Breast Cancer
100%
Chromosomal Instability
81%
Pesticides
54%
Clonal Heterogeneity
54%
Colombians
54%
Comparative Transcriptome Analysis
54%
Exosomes
49%
Androgen Receptor
40%
Chromosome Rearrangement
40%
MicroRNA
35%
Non-coding RNA (ncRNA)
31%
Breast Cancer Cells
29%
BRCA1, BRCA2
27%
Germline BRCA1/2 mutation
27%
RNA Interaction
27%
Primary Breast Angiosarcoma
27%
Integrative Network Analysis
27%
Obesity Receptor
27%
RNA Exosome
27%
Antitumor Immune Response
27%
Clonal Chromosome Aberrations
27%
Molecular Genomics
27%
Resistance Resistance
27%
Overcoming Resistance
27%
Therapy Response
27%
Androgen Receptor Gene
27%
Primary Breast Cancer
27%
Intrinsic Subtype
27%
Tumor Cells
27%
Biological Characteristics
27%
Adipokines
27%
Breast Cancer Susceptibility Gene 1 (BRCA1)
27%
Bioinformatics Tools
27%
Cancer Patients
27%
African Ancestry
27%
Breast Cancer Cell Lines
27%
Early Onset
27%
Asbestos
27%
Immune Cells
27%
Gene Expression
27%
Meta-analysis
27%
Circulating Blood
27%
High Prevalence
27%
Androgen Signaling
27%
Biomarkers of Effect
27%
Biomarkers of Susceptibility
27%
Molecular Characteristics
27%
Organic Solvents
27%
Car Painters
27%
Genetic Damage
27%
Exposure to Pesticides
23%
Obesity
20%
Angiosarcoma
18%
Occupational Exposure
16%
Molecular Mechanism
16%
Breast Cancer Patients
16%
Micronucleated Cells
16%
CYP2E1 Polymorphism
16%
Micronucleus
16%
In Cancer
16%
Afro-Colombian
15%
Estrogen Receptor
15%
Patients with Breast Cancer
14%
Breast Cancer Subtypes
14%
Androgens
13%
Mestizo
11%
Poor Prognosis
11%
Resistance to Treatment
10%
Basal-like
10%
Clinical Problems
10%
Clinical Parameters
10%
MRNA Level
10%
Lung Cancer
10%
Nucleoplasmic Bridge
10%
Pulmonary Disease
10%
Genotype
10%
Herceptin
9%
Docetaxel
9%
Cancer Cells
9%
Lymphedema
9%
Neoplastic Tissue
9%
Transcriptome Studies
9%
White Women
9%
Exposure Radiation
9%
Intraluminal Vesicles
9%
Family Cancer History
9%
CD34
9%
Comparative Transcriptome
9%
CD31
9%
FLI1
9%
Healthy Tissue
9%
Neoplasms
9%
Public Database
9%
Knowledge Level
9%
Healthy Individuals
9%
Differential Diagnosis
9%
Tumor Tissue
9%
Non-associated
9%
Rare Pathology
9%
Immunostaining
9%
Biochemistry, Genetics and Molecular Biology
Chromosome Instability
81%
Non-Coding RNA
54%
Prevalence
54%
Cancer Cell
54%
Androgen Receptor
54%
MicroRNA
40%
Gene Expression
31%
BRCA1
27%
Adipokine
27%
Bioinformatics
27%
Gene Expression Profiling
27%
Transcriptome
27%
Receptor Gene
27%
CYP2E1
27%
Germline Mutation
27%
Immune Response
27%
Immunocompetent Cell
27%
Lipid
27%
Nucleic Acid
17%
Cytogenetics
16%
Estrogen Receptor
16%
Messenger RNA
15%
Translocator Protein
13%
Membrane Invagination
13%
Membrane Lipid
13%
Immunoregulation
13%
Genotyping
13%
Anabolism
13%
Homeostasis
13%
Ceramide
13%
DNA RNA Hybridization
13%
Secretion (Process)
13%
Phosphatidylserine
13%
Peripheral Blood Lymphocyte
13%
Tumor Escape
13%
Cell Membrane
13%
Cellular Differentiation
13%
Somatic Cell
12%
Chromosome Variant
10%
Fluorescence in Situ Hybridization
10%
Trastuzumab
9%
Doxorubicin
9%
Adipocyte
6%
Adiponectin
6%
Hormone Release
6%
Monosomy
6%
Lymphocyte
6%
Allele
6%
Cross Sectional Study
6%
Chromosome Analysis
6%
Leptin
6%
Awareness
5%